openPR Logo
Press release

Expansion of Toxoplasmosis Infection Treatment Market to Remain Consistent During 2017-2027

12-01-2017 07:26 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Expansion of Toxoplasmosis Infection Treatment Market

Toxoplasmosis caused by a single celled parasite called “Toxoplasma gondii”, which results in an infection usually occurs by raw or undercooked contaminated meat particularly lamb or pork, drinking contaminated water and milk from an infected goat, exposure from cat feces, mother to child transmission during pregnancy and organs transplantation in rare cases.

Toxoplasmosis Infections causes flu like symptoms including muscle ache, body ache, fever, headache, sore throat, fatigue, swollen lymph nodes and swollen glands etc. People with weakened immune system develop more severe signs of infection and inflammation including brain inflammation, lung infection, poor coordination and blurred vision and eye infection.

Some factors including HIV/AIDS positive individuals, or undergoing chemotherapy patients and pregnant ladies having a risk of serious health problems. Medication for HIV/AIDS positive individuals, consist pyrimethamine and sulfadiazine, with folinic acid (leucovorin) given on the treatment choice. Pyrimethamine with clindamycin (Cleocin) used as an alternative source. Sulfadiazine, which is an antibiotic used in combination with pyrimethamine to treat toxoplasmosis. During pregnancy, if the infection occurred after the 16th week, spiramycin (antibiotic) recommended in the first three months or in the second early trimester to treat the infection that reduces the risk of neurological problems in the baby. The combination of sulfadoxine with pyrimethamine is also used to prevent certain types of malaria. The treatment of toxoplasmosis includes a blood test to check the presence of antibodies of the related parasite.

Doctors typically prescribe medication consist antibiotic to treat the infection. The medication is depending on eye lesion size, type of the lesion (acute active, versus chronic not progressing) and the location of the infection.

Read Report Overview@ https://www.futuremarketinsights.com/reports/toxoplasmosis-infection-treatment-market

Toxoplasmosis Infection Treatment Market: Drivers and Restrains

The toxoplasmosis infection treatment market is expected to be driven by the rising health awareness, high incidences of foodborne illness. With the increasing incidence of toxoplasmosis, and high investment in toxoplasmosis research, the market is expected to grow during the forecast period. However, certain side effects of high dosage drugs that includes blood disorders, allergic reactions, tongue changes and anorexia etc are posing a restrain to toxoplasmosis infection treatment market.

Toxoplasmosis Infection Treatment Market: Segmentation

The global toxoplasmosis infection treatment market is classified on the drug type and the distribution channel.

Global Toxoplasmosis Infection Treatment Market, by drugs type-

Pyrimethamine Combination

Sulfadiazine Combination

Leucovorin Combination (Folinic acid)

Spiramycin Combination

Clindamycin Combination

Atovaquone Combination

Global Toxoplasmosis Infection Treatment Market, by distribution channel-

Hospital Pharmacies

Drug stores

Retail pharmacy

E-commerce

Others

Toxoplasmosis Infection Treatment Market: Overview

The toxoplasmosis infection treatment market is expected to growth at a healthy growth rate during the forecast period. This is due to high incidence of Toxoplasmosis, an infectious disease caused by a protozoan. Government initiatives to prevent risk of toxoplasmosis and other infection from food is expected to drive the market during the forecast years.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4923

Toxoplasmosis Infection Treatment Market: Regional overview

Region wise, the global toxoplasmosis infection treatment market is classified into seven regions namely North America, Latin America, Eastern Europe, Western Europe, Japan, Asia-Pacific excluding Japan, Middle East and Africa. North America is expected to hold the highest market share with strong growth of pyrimethamine treatment market. Better government initiatives to educate people on the prevention of toxoplasmosis would reduce risk in the environment and open more business opportunities for research and development. The second largest market hold by Europe market followed by Asia pacific excluding Japan.

Toxoplasmosis Infection Treatment Market: Key Players

Some of the major players in toxoplasmosis infection treatment market include Impax Laboratories Inc., Turing Pharmaceuticals, Lupin Limited, Amneal Pharmaceuticals, Turing pharmaceuticals LLC, Pharmaceuticals LLC, Novartis International AG, F. Hoffmann-La Roche AG., Gilead Sciences, Greenstone LLC and others.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Expansion of Toxoplasmosis Infection Treatment Market to Remain Consistent During 2017-2027 here

News-ID: 840508 • Views: 145

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Toxoplasmosis

Toxoplasmosis Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Pipeline Review, H1 2017, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. Get Sample Copy http://www.reportsweb.com/inquiry&RW0001858649/sample Report Highlights Publisher's Pharmaceutical and
Toxoplasmosis Testing Market Valuation By 2021
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and
Toxoplasmosis Industry Assessment And Therapeutics Analysis Forecasts To 2017
Overview Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740059-toxoplasmosis-pipeline-review-h2-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Toxoplasmosis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Toxoplasmosis (Infectious
Market Overview of Toxoplasmosis Research and Detailed Forecast 2018
Summary Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2740059-toxoplasmosis-pipeline-review-h2-2017 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Toxoplasmosis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Toxoplasmosis (Infectious Disease), complete
Recent Research: Toxoplasmosis Testing Market Analysis to 2021
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and
Toxoplasmosis - Pipeline Review, Industry Analysis, Trends, and Forecast Report …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Toxoplasmosis - Pipeline Review, H1 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196658 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Pipeline Review, H1 2017, provides an overview of the